Artificial Intelligence Aids Scientists in Uncovering Hallmarks of Mystery Concussion
New research is paving the way to a precision medicine approach to the diagnosis and treatment of patients with traumatic brain injury.
![](/sites/default/files/styles/news_card__image/public/fields/field_insert_file/news/examining_brain_scans.jpg)
University of California San Francisco
Give to UCSFNew research is paving the way to a precision medicine approach to the diagnosis and treatment of patients with traumatic brain injury.
A molecular key to aging of the blood and immune system has been discovered in new research conducted at UCSF.
A type of herpes virus that infects about half of the U.S. population has been associated with risk factors for type 2 diabetes and heart disease in normal-weight women aged 20 to 49.
Research uses brain “organoids” — tiny 3D models of human organs that scientists grow in a dish to study disease — to identify root causes of MDS, a rare genetic disorder that causes fatal brain malformations.
Poor performance on a simple odor identification test was associated with a significantly increased risk of developing dementia years later.
Distinct sets of genetic defects in a single neuronal protein can lead either to infantile epilepsy or to autism spectrum disorders.
A common treatment for irregular heartbeats known as catheter ablation may result in the formation of brain lesions when it is performed on the left side of the heart.
For concussion sufferers, physicians may now be able to predict early on who is more likely to continue experiencing symptoms months or years after the head-jarring event.
Children with severe cases of epilepsy such as Dravet syndrome are finding new and unexpected cures thanks to determined pediatricians and translational research at UCSF.
UC San Francisco and Pfizer Inc.’s Centers for Therapeutic Innovation have renewed an agreement to identify and develop biologic compounds against both known and novel targets.
Researchers at UCSF have developed a new optogenetic tool that can be used to completely eliminate single cells from brain networks in animals. The researchers believe the new tool will enable exquisitely precise experiments to help researchers understand how each cell contributes to the whole.
In findings that show the effectiveness of a new strategy for treating multiple sclerosis, researchers are reporting positive results from three large, international, multicenter Phase III clinical trials of the investigational drug ocrelizumab in both relapsing multiple sclerosis and primary progressive multiple sclerosis.
UCSF scientists have discovered an unexpected mechanism the brain uses to seamlessly compensate when speech sounds are obscured by noise.
Stories about sensory processing disorder, videos about “zombie” cancer cells, and news about the effects of caffeine and alcohol on the heart were among the topics that most engaged our readers in 2016.
Beta blockers are effective in reducing the risk of death in older nursing home residents after a heart attack, but may impair their ability to perform daily functions independently.